|
1
|
Lee WM: Hepatitis B virus infection. N
Engl J Med. 337:1733–1745. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dienstag JL: Hepatitis B virus infection.
N Engl J Med. 359:1486–1500. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maini MK, Boni C, Ogg GS, King AS, Reignat
S, Lee CK, Larrubia JR, Webster GJ, McMichael AJ, Ferrari C,
Williams R, Vergani D and Bertoletti A: Direct ex vivo analysis of
hepatitis B virus-specific CD8+T cells associated with
the control of infection. Gastroenterology. 117:1386–1396. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang FS and Zhang Z: Host immunity
influences disease progression and antiviral efficacy in humans
infected with hepatitis B virus. Expert Rev Gastroenterol Hepatol.
3:499–512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z,
Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX and Wang FS:
Circulating and liver resident CD4+CD25+
regulatory T cells actively influence the antiviral immune response
and disease progression in patients with hepatitis B. J Immunol.
177:739–747. 2006.PubMed/NCBI
|
|
6
|
Tadokoro CE, Shakhar G, Shen S, Ding Y,
Lino AC, Maraver A, Lafaille JJ and Dustin ML: Regulatory T cells
inhibit stable contacts between CD4+ T cells and
dendritic cells in vivo. J Exp Med. 203:505–511. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stoop JN, van der Molen RG, Baan CC, van
der Laan LJ, Kuipers EJ, Kusters JG and Janssen HL: Regulatory T
cells contribute to the impaired immune response in patients with
chronic hepatitis B virus infection. Hepatology. 41:771–778. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Chen Y, Ma Z, Ye B, Wu W and Li L:
Effect of regulatory T cells and adherent cells on the expansion of
HBcAg-specific CD8+ T cells in patients with chronic
hepatitis B virus infection. Cell Immunol. 264:42–46. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beyer M, Thabet Y, Müller RU, Sadlon T,
Classen S, Lahl K, Basu S, Zhou X, Bailey-Bucktrout SL, Krebs W, et
al: Repression of the genome organizer SATB1 in regulatory T cells
is required for suppressive function and inhibition of effector
differentiation. Nat Immunol. 12:898–907. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burute M, Gottimukkala K and Galande S:
Chromatin organizer SATB1 is an important determinant of T-cell
differentiation. Immunol Cell Biol. 90:852–859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nie H, Maika SD, Tucker PW and Gottlieb
PD: A role for SATB1, a nuclear matrix association region-binding
protein, in the development of CD8SP thymocytes and peripheral T
lymphocytes. J Immunol. 174:4745–4752. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamaguchi H, Tateno M and Yamasaki K:
Solution structure and DNA-binding mode of the matrix attachment
region-binding domain of the transcription factor SATB1 that
regulates the T-cell maturation. J Biol Chem. 281:5319–5327. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chinese Society of Hepatology, Chinese
Medical Association; Chinese Society of Infectious Diseases,
Chinese Medical Association. Guideline on prevention and treatment
of chronic hepatitis B in China (2005). Chin Med J (Engl).
120:2159–2173. 2007.PubMed/NCBI
|
|
14
|
Szodoray P, Papp G, Horvath IF, Barath S,
Sipka S, Nakken B and Zeher M: Cells with regulatory function of
the innate and adaptive immune system in primary Sjögren’s
syndrome. Clin Exp Immunol. 157:343–349. 2009.PubMed/NCBI
|
|
15
|
Franzese O, Kennedy PT, Gehring AJ, Gotto
J, Williams R, Maini MK and Bertoletti A: Modulation of the
CD8+-T-cell response by CD4+ CD25+
regulatory T cells in patients with hepatitis B virus infection. J
Virol. 79:3322–3328. 2005.PubMed/NCBI
|
|
16
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galande S, Dickinson LA, Mian IS, Sikorska
M and Kohwi-Shigematsu T: SATB1 cleavage by caspase 6 disrupts PDZ
domain-mediated dimerization, causing detachment from chromatin
early in T-cell apoptosis. Mol Cell Biol. 21:5591–5604. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to promote
breast tumour growth and metastasis. Nature. 452:187–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patani N, Jiang W, Mansel R, Newbold R and
Mokbel K: The mRNA expression of SATB1 and SATB2 in human breast
cancer. Cancer Cell Int. 9:182009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng C, Lu X, Wang G, Zheng L, Shu X, Zhu
S, Liu K, Wu K and Tong Q: Expression of SATB1 and heparanase in
gastric cancer and its relationship to clinicopathologic features.
APMIS. 118:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu X, Cheng C, Zhu S, Yang Y, Zheng L,
Wang G, Shu X, Wu K, Liu K and Tong Q: SATB1 is an independent
prognostic marker for gastric cancer in a Chinese population. Oncol
Rep. 24:981–987. 2010.PubMed/NCBI
|
|
22
|
Meng WJ, Yan H, Zhou B, Zhang W, Kong XH,
Wang R, Zhan L, Li Y, Zhou ZG and Sun XF: Correlation of SATB1
overexpression with the progression of human rectal cancer. Int J
Colorectal Dis. 27:143–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H,
He J, Han P and Tian D: Upregulation of SATB1 promotes tumor growth
and metastasis in liver cancer. Liver Int. 32:1064–1078. 2012.
View Article : Google Scholar
|
|
24
|
Zheng Y, Huang Z, Chen X, Tian Y, Tang J,
Zhang Y, Zhang X, Zhou J, Mao Q, Ni B, Wang Q and Wu Y: Effects of
telbivudine treatment on the circulating CD4+ T-cell
subpopulations in chronic hepatitis B patients. Mediators Inflamm.
2012:7898592012. View Article : Google Scholar : PubMed/NCBI
|
